Wastewater treatment technology from Bluewater Bio to be marketed across North America by Infilco Degremont

Sponsored by

Oct. 31, 2011 -- Bluewater Bio International, provider of the HYBACS wastewater treatment process, has entered into an agreement with Infilco Degremont, Inc (SUEZ Environnement) to market technology for energy-efficient nutrient removal across North America.

Under the agreement, which the companies executed several months ago, Infilco Degremont ("IDI") will provide HYBACS to municipal and industrial wastewater treatment plants across the continent.

Following nearly two years of increasingly close collaboration, the two companies are working towards the deployment of a full-scale HYBACS demonstration plant in the NE region of the country, where reliable nutrient removal technologies are in particularly high demand driven by stringent regulations.

Bluewater Bio has supplied one of its SMART™ Units, which drives the HYBACS process, and IDI has supplied the plant, including aeration tanks and clarifiers, into which the SMART Unit™ is being installed. The plant as a whole has been designed by IDI to be mobile, despite its large size, and the customized SMART Unit™ allows for the flexibility to operate on different flows and loads at other sites in the future. The demo plant is expected to be installed at site by the end of November 2011, and will be one of IDI's largest.

Infilco Degremont believes there is an excellent market for HYBACS to deliver a cost effective solution for the nutrient removal market and highlight the low energy consumption and ease of upgrade as key advantages in the US market. Tony Hargrave, Chief Executive Officer of Infilco Degremont commented: "IDI has been working very closely with Bluewater Bio for quite some time to bring this project to fruition as we now prepare to launch this technology in the US, as part of IDI's portfolio of wastewater technologies. We see great potential and many opportunities for HYBACS in North America."

Daniel Ishag, CEO Bluewater Bio, commented: "This marks an exciting development in the history of Bluewater Bio and we have worked closely with IDI in the USA. The US is an enormous prospective market for HYBACS, particularly as a significant proportion of waste water assets were installed in the 1950's and 60's, and HYBACS is perfectly suited to the upgrading of such plants which is frequently required. Bluewater Bio has worked hard to establish itself in international markets such as Europe, Africa, Middle East and China and we could not wish for a better partner to now go forward with into North America over the coming years."

###

Sponsored by

TODAY'S HEADLINES

MWRD to participate in National Prescription Drug Take-Back Day

On Saturday, Sept. 27, the Metropolitan Water Reclamation District of Greater Chicago is joining the U.S. Drug Enforcement Administration's national unwanted medicine "Take-Back" initiative to collect pharmaceuticals at three local facilities to prevent contamination of waterbodies.

Wastewater PPCPs can contaminate shallow groundwater following release to streams, finds study

According to a new USGS study, pharmaceuticals and other contaminants from treated municipal wastewater are able to travel into shallow groundwater following their release to streams.

 

UK wastewater treatment plant receives progressing cavity pump to help improve water quality

NOV Mono has delivered a turnkey project to provide an extra level of protection for the Dwr Cymru Crymych treatment plant in Pembrokeshire, a county in the Southwest of Wales. The project centers on an EZstrip progressing cavity pump to ensure the quality of treated sewage.

New partnership to offer innovative smart pressure management solutions

Itron has announced a new alliance with i2O Water. The collaboration will expand Itron's water portfolio and complete its non-revenue water offering, enabling utilities to more effectively and efficiently manage water resources across the globe.

FOLLOW US ON SOCIAL MEDIA